Request Your Free White Paper Now:

"Tips for Securing Funding and Providing Confidence to Investors"

Tips for Securing Funding and Providing Confidence to Investors In 2023, the PPD® clinical research business of Thermo Fisher Scientific surveyed 150 global drug development leaders to assess industry trends, challenges and sentiments. The survey revealed that nearly 40% of respondents from biotech companies reported lack of funding as one of the challenges facing their organization.

A risk-averse financial climate, paired with a growing industry and a decline in biotech investing at  

scale, has created a difficult and competitive environment for emerging biotech companies that rely  

heavily on outside investors to bring new assets to market. As such, the recipe for success requires  

biotech companies to stand out among the sea of noise, bringing heightened assurance to investors  

that their projects will succeed. 

This paper explores: 

• The current and future state of the investment landscape,  

• How biotech companies can become more attractive to investors, and  

• How to bring clarity, speed and assurance to venture capital partners. 

Offered Free by: PPD
See All Resources from: PPD